Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010

Tiffany G. Sheu, Alicia M. Fry, Rebecca J. Garten, Varough M. Deyde, Thein Shwe, Lesley Bullion, Patrick J. Peebles, Yan Li, Alexander I. Klimov, Larisa V. Gubareva

Research output: Contribution to journalArticlepeer-review

120 Scopus citations

Abstract

Two distinct genetic clades of seasonal influenza A(H1N1) viruses have cocirculated in the recent seasons: clade 2B oseltamivir-resistant and adamantane-susceptible viruses, and clade 2C viruses that are resistant to adamantanes and susceptible to oseltamivir. We tested seasonal influenza A(H1N1) viruses collected in 2008-2010 from the United States and globally for resistance to antivirals approved by the Food and Drug Administration. We report 28 viruses with both adamantane and oseltamivir (dual) resistance from 5 countries belonging to 4 distinct genotypes. Because of limited options for antiviral treatment, emergence of dual-resistant influenza viruses poses a public health concern, and their circulation needs to be closely monitored.

Original languageEnglish (US)
Pages (from-to)13-17
Number of pages5
JournalJournal of Infectious Diseases
Volume203
Issue number1
DOIs
StatePublished - Jan 1 2011

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010'. Together they form a unique fingerprint.

Cite this